Stuart H. Cohen
Impact in
- Infectious Diseases top 0.1%
- Clostridium difficile and Clostridium perfringens research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- Antifungal resistance and susceptibility
-
- Nosocomial Infections in ICU
Papers in
-
- Clostridium difficile and Clostridium perfringens research 44
- Antimicrobial Resistance in Staphylococcus 14
- Viral gastroenteritis research and epidemiology 14
- Antifungal resistance and susceptibility 13
- SARS-CoV-2 and COVID-19 Research 9
- Epidemiology 52
- Fungal Infections and Studies 15
- Microscopic Colitis 15
- Co-authors
- Dale N. Gerding (3 shared papers)Vivian G. Loo (2 shared papers)Ciarán P. Kelly (2 shared papers)Stuart Johnson (2 shared papers)Mark H. Wilcox (2 shared papers)L. Clifford McDonald (2 shared papers)Christopher R. Polage (8 shared papers)Jay V. Solnick (6 shared papers)
- Journals
- Clinical Infectious Diseases (17 papers)Infection Control and Hospital Epidemiology (12 papers)Diagnostic Microbiology and Infectious Disease (11 papers)Journal of Clinical Microbiology (9 papers)Open Forum Infectious Diseases (7 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Stuart H. Cohen
130 papers receiving 11.3k citations
Stuart H. Cohen's Hit Papers
Peers
Comparison fields: 5 of 164
- Infectious Diseases 7.7k
- Critical Care and Intensive Care Medicine 744
- Applied Microbiology and Biotechnology 208
- Epidemiology 3.4k
- Neurology 1.0k
Countries citing papers authored by Stuart H. Cohen
This map shows the geographic impact of Stuart H. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart H. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart H. Cohen more than expected).
Fields of papers citing papers by Stuart H. Cohen
This network shows the impact of papers produced by Stuart H. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart H. Cohen. The network helps show where Stuart H. Cohen may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart H. Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Hit paper breakdown → | 2010 | 2496 |
| 2 | Compassionate Use of Remdesivir for Patients with Severe Covid-19 Hit paper breakdown → | 2020 | 2154 |
| 3 | Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 Hit paper breakdown → | 2020 | 1402 |
| 4 | Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis Hit paper breakdown → | 2019 | 755 |
| 5 | Hospital Epidemiology and Infection Control Hit paper breakdown → | 1996 | 663 |
| 6 | Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era Hit paper breakdown → | 2015 | 475 |
| 7 | 2003 | 354 | |
| 8 | 2015 | 279 | |
| 9 | 2000 | 171 | |
| 10 | 2006 | 150 | |
| 11 | 2012 | 149 | |
| 12 | 1995 | 138 | |
| 13 | 2012 | 135 | |
| 14 | 2022 | 118 | |
| 15 | 2000 | 105 | |
| 16 | 2022 | 95 | |
| 17 | Mesiotemporal T2-weighted hyperintensity: neurosyphilis mimicking herpes encephalitis. | 2001 | 87 |
| 18 | 1991 | 83 | |
| 19 | 2020 | 75 | |
| 20 | 2001 | 70 |
About Stuart H. Cohen
Stuart H. Cohen is a scholar working on Infectious Diseases, Epidemiology, Critical Care and Intensive Care Medicine, Parasitology and Clinical Biochemistry, having authored 136 papers that have together received 11.8k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (44 papers), Fungal Infections and Studies (15 papers), Microscopic Colitis (15 papers), Antimicrobial Resistance in Staphylococcus (14 papers), Viral gastroenteritis research and epidemiology (14 papers), Antifungal resistance and susceptibility (13 papers), Nosocomial Infections in ICU (9 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). The work is most often cited by research in Infectious Diseases (7.7k citations), Critical Care and Intensive Care Medicine (744 citations), Applied Microbiology and Biotechnology (208 citations), Epidemiology (3.4k citations) and Neurology (1.0k citations). Stuart H. Cohen has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Dale N. Gerding, Vivian G. Loo, Ciarán P. Kelly, Stuart Johnson, Mark H. Wilcox, L. Clifford McDonald, Christopher R. Polage, Jay V. Solnick, George R. Thompson and Yajarayma J. Tang. Their work appears in journals such as Clinical Infectious Diseases, Infection Control and Hospital Epidemiology, Diagnostic Microbiology and Infectious Disease, Journal of Clinical Microbiology and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.